See more : TransAtlantic Capital Inc. (TACI) Income Statement Analysis – Financial Results
Complete financial analysis of Ondine Biomedical Inc. (OBI.L) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Ondine Biomedical Inc., a leading company in the Biotechnology industry within the Healthcare sector.
- CBD Global Sciences Inc. (CBDNF) Income Statement Analysis – Financial Results
- Neovacs S.A. (ALNEV.PA) Income Statement Analysis – Financial Results
- Semilux International Ltd. Ordinary Shares (SELX) Income Statement Analysis – Financial Results
- Nukkleus Inc. (NUKK) Income Statement Analysis – Financial Results
- Microsoft Corporation (MSFT) Income Statement Analysis – Financial Results
Ondine Biomedical Inc. (OBI.L)
About Ondine Biomedical Inc.
Ondine Biomedical Inc., a Life sciences company, engages in the research, development, and commercialization of antimicrobial photodisinfection therapies in Canada and internationally. Its product platform is Photodisinfection, a topical light-based antimicrobial technology that eliminates harmful pathogens. The company's lead product is Steriwave, a photodisinfection based medical device that eliminates harmful nasal pathogens, which leads to healthcare-associated infections. Its product pipeline also includes development of a topical antiviral therapy for the upper respiratory tract that reduces SARS-CoV-2 titre and transmission; a solution for treatment of chronic rhinosinusitis; OND1002, a solution for disinfection of endotracheal tubes to reduce the incidence of ventilator-associated pneumonia; and OND1003, a solution for decolonization of burns and wounds. The company was incorporated in 1996 and is headquartered in Vancouver, Canada.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2003 | 2002 | 2001 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 1.20M | 638.00K | 2.57M | 1.79M | 464.00K | 373.00K | 412.00K | 1.53M | 1.03M | 912.33K | 1.61M | 1.62M | 0.00 | 0.00 | 0.00 | 0.00 |
| Cost of Revenue | 500.00K | 351.00K | 1.32M | 1.14M | 328.00K | 485.00K | 311.00K | 313.66K | 219.19K | 726.49K | 784.84K | 1.02M | 0.00 | 0.00 | 0.00 | 0.00 |
| Gross Profit | 703.00K | 287.00K | 1.25M | 649.00K | 136.00K | -112.00K | 101.00K | 1.22M | 811.04K | 185.84K | 820.65K | 604.12K | 0.00 | 0.00 | 0.00 | 0.00 |
| Gross Profit Ratio | 58.44% | 44.98% | 48.81% | 36.24% | 29.31% | -30.03% | 24.51% | 79.54% | 78.72% | 20.37% | 51.12% | 37.31% | 0.00% | 0.00% | 0.00% | 0.00% |
| Research & Development | 5.14M | 6.28M | 4.98M | 3.31M | 3.42M | 4.09M | 3.27M | 3.25M | 2.85M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 8.01M | 10.91M | 12.97M | 10.41M | 6.86M | 9.85M | 2.41M | 1.89M | 1.96M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Selling & Marketing | 1.79M | 1.40M | 364.00K | 1.63M | 2.70M | 1.58M | 333.00K | 15.28K | 443.61K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 9.80M | 12.31M | 13.33M | 12.04M | 9.55M | 11.43M | 2.74M | 1.91M | 2.41M | 9.93M | 13.67M | 12.67M | 8.76M | 82.95K | 69.60K | 74.95K |
| Other Expenses | 570.00K | 460.00K | 458.00K | 1.17M | 1.19M | -30.00K | 52.00K | 889.60K | 95.51K | 340.83K | 371.74K | 244.04K | 111.79K | 0.00 | 11.84K | 0.00 |
| Operating Expenses | 15.51M | 19.05M | 18.77M | 16.52M | 14.16M | 16.42M | 5.88M | 5.40M | 5.51M | 10.27M | 14.04M | 12.91M | 8.87M | 82.95K | 69.60K | 74.95K |
| Cost & Expenses | 16.01M | 19.40M | 20.09M | 17.66M | 14.49M | 16.91M | 6.19M | 5.71M | 5.72M | 11.00M | 14.82M | 13.93M | 8.87M | 82.95K | 69.60K | 74.95K |
| Interest Income | 242.00K | 191.00K | 0.00 | 0.00 | 0.00 | 291.00K | 0.00 | 22.08K | 13.81K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Expense | 38.00K | 30.00K | 1.20M | 491.00K | 179.00K | 127.00K | 809.00K | 0.00 | 30.42K | 181.90K | 0.00 | 0.00 | -411.12K | 3.00 | 1.46M | 0.00 |
| Depreciation & Amortization | 587.00K | 493.00K | 514.00K | 1.22M | 1.22M | 922.00K | 175.00K | 298.30K | 251.22K | 340.83K | 371.74K | 244.04K | 111.79K | 6.00 | 2.95M | 0.00 |
| EBITDA | -13.79M | -18.85M | -16.84M | -14.56M | -12.59M | -15.61M | -5.45M | -3.88M | -4.53M | -9.75M | -12.85M | -12.06M | -8.76M | -82.95K | 1.41M | -74.95K |
| EBITDA Ratio | -1,146.05% | -2,733.07% | -655.51% | -797.04% | -2,713.79% | -4,184.99% | -1,322.82% | -253.26% | -424.46% | -1,068.37% | -800.18% | -745.11% | 0.00% | 0.00% | 0.00% | 0.00% |
| Operating Income | -14.81M | -18.76M | -17.52M | -15.87M | -14.03M | -16.53M | -5.78M | -4.18M | -4.62M | -10.09M | -13.22M | -12.31M | -8.87M | -82.95K | -1.54M | -74.95K |
| Operating Income Ratio | -1,230.67% | -2,940.91% | -681.98% | -886.15% | -3,023.28% | -4,432.17% | -1,401.94% | -272.72% | -448.84% | -1,105.73% | -823.33% | -760.18% | 0.00% | 0.00% | 0.00% | 0.00% |
| Total Other Income/Expenses | 393.00K | -609.00K | -32.57M | -336.00K | 38.00K | -127.00K | -658.00K | 911.68K | -30.42K | -181.90K | 58.77K | 396.33K | 411.12K | -3.00 | -1.46M | 0.00 |
| Income Before Tax | -14.41M | -19.37M | -50.09M | -16.21M | -13.99M | -16.66M | -6.43M | -3.27M | -4.65M | -10.27M | -13.16M | -11.91M | -8.46M | -82.96K | -3.01M | 0.00 |
| Income Before Tax Ratio | -1,198.00% | -3,036.36% | -1,949.59% | -904.91% | -3,015.09% | -4,466.22% | -1,561.65% | -213.24% | -451.79% | -1,125.66% | -819.67% | -735.70% | 0.00% | 0.00% | 0.00% | 0.00% |
| Income Tax Expense | 0.00 | 1.41M | 32.73M | 710.00K | 174.00K | 124.00K | 658.00K | -11.84K | -59.05K | 181.90K | -2.17K | 50.50K | 75.20K | 1.39K | -7.52K | -1.66K |
| Net Income | -14.41M | -20.78M | -82.82M | -16.92M | -14.16M | -16.66M | -6.43M | -3.26M | -4.60M | -10.27M | -13.15M | -11.96M | -8.54M | -84.34K | -1.54M | -73.29K |
| Net Income Ratio | -1,198.00% | -3,257.68% | -3,223.67% | -944.56% | -3,052.59% | -4,465.42% | -1,561.65% | -212.47% | -446.06% | -1,125.66% | -819.34% | -738.82% | 0.00% | 0.00% | 0.00% | 0.00% |
| EPS | -0.07 | -0.11 | -1.04 | -0.09 | -0.07 | -0.09 | -0.03 | -0.40 | -0.83 | -0.17 | -0.24 | -0.25 | -0.21 | -0.06 | -1.14 | -0.05 |
| EPS Diluted | -0.07 | -0.11 | -1.04 | -0.09 | -0.07 | -0.09 | -0.03 | -0.40 | -0.83 | -0.17 | -0.24 | -0.25 | -0.21 | -0.06 | -1.14 | -0.05 |
| Weighted Avg Shares Out | 197.11M | 194.59M | 79.64M | 194.58M | 194.58M | 194.58M | 194.58M | 8.20M | 5.51M | 61.28M | 55.08M | 47.91M | 40.57M | 1.35M | 1.35M | 1.36M |
| Weighted Avg Shares Out (Dil) | 197.11M | 194.59M | 79.64M | 194.58M | 194.58M | 194.58M | 194.58M | 8.20M | 5.51M | 61.28M | 55.08M | 47.91M | 40.57M | 1.35M | 1.35M | 1.36M |
Source: https://incomestatements.info
Category: Stock Reports